This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Eric J Sandquiest: Innovator in Migraine Treatment
Introduction
Eric J Sandquiest is a notable inventor based in Doylestown, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of migraines. His innovative approach combines a 5HT agonist and a COX-2 selective inhibitor, showcasing his dedication to improving patient care.
Latest Patents
Eric holds a patent for a method of treating migraines and pharmaceutical compositions. This patent is particularly important as it addresses the treatment and prevention of migraines, providing a new avenue for relief to those suffering from this debilitating condition. He has 1 patent to his name, reflecting his focused contributions to medical science.
Career Highlights
Eric is currently employed at Merck & Co., Inc., a leading global healthcare company. His work at Merck has allowed him to collaborate with other talented professionals in the field, further enhancing his impact on pharmaceutical innovations.
Collaborations
Some of his notable coworkers include Scott A Reines and Deepak K Khanna. Their collective expertise contributes to the advancement of research and development in migraine treatment.
Conclusion
Eric J Sandquiest exemplifies the spirit of innovation in the pharmaceutical industry. His work not only highlights the importance of collaboration but also emphasizes the potential for new treatments that can significantly improve the quality of life for migraine sufferers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile